
The price of migraine drug prochlorperazine rose 700% in four years
(Picture: PA Archive)Private equity group Cinven has been hit with a third fine linked to price gouging on drugs sold to the NHS.
The Competition and Markets Authority today fined four drug companies a collective £35 million, with part of the fines passed on to the owners of one business. Cinven will share a £15.5 million fine due to its historic ownership of drug distributor Focus.